In vitro activity of ampicillin or vancomycin combined with gentamicin or streptomycin against enterococci.
about
Combined effect of amphotericin B and rifampin on Candida speciesTransferable vancomycin and teicoplanin resistance in Enterococcus faecium.Drastic therapy for listerial brain abscess involving combined hyperbaric oxygen therapy and antimicrobial agents.Resistance of enterococci to glycopeptides.In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalisAlanine aminopeptidase and beta 2-microglobulin excretion in patients receiving vancomycin and gentamicin.Antimicrobial susceptibility changes in Enterococcus faecalis following various penicillin exposure regimens.Low prevalence of VRE gastrointestinal colonization of hospitalized patients in Manitoba tertiary care and community hospitals.Penicillin and netilmicin in treatment of experimental enterococcal endocarditis.High-level vancomycin-resistant enterococci causing hospital infectionsResistance to vancomycin and teicoplanin: an emerging clinical problem.Detection of vancomycin resistance in Enterococcus species.Problems with the disk diffusion test for detection of vancomycin resistance in enterococci.Antimicrobial resistance among enterococci.An analysis of group D streptococci recovered from cancer patients.Vancomycin: an update.Combined in vitro effect of amphotericin B and rifampin on Cryptococcus neoformans.Bioassay for determination of vancomycin in the presence of rifampin or aminoglycosides.Defective killing of enterococci: a common property of antimicrobial agents acting on the cell wall.Comparative in vitro activity of nafcillin, oxacillin, and methicillin in combination with gentamicin and tobramycin against enterococci.Enterococcus, an emerging pathogen.Comparative activity of daptomycin and teicoplanin against enterococci isolated from blood and urine.Characterization of the unique function of a reduced amide bond in a cytolytic peptide that acts on phospholipid membranes.Effects of a vancomycin-rifampin combination on enterococci.In-vitro activity of ciprofloxacin and sixteen other antimicrobial agents against blood culture isolates.
P2860
Q28367198-DE1CD75F-227C-49D5-8280-A2F6DD034B39Q34042099-A3607313-A6B0-4E5D-8201-0584E241FFC2Q34346586-B67E4476-7131-4654-A516-B7BB31A7A012Q35284014-4374EA48-4C4A-4938-956C-5C2F7000F63EQ35350299-7BDA7077-13DB-4103-A1F7-638E5D6F00E6Q35542081-49084DFF-5B44-4CDD-92EC-E59B91061581Q35843281-41EE7424-0FFD-41A4-8E14-C15878865502Q36170120-F4C53DA9-1724-4E51-BEDB-0AB60E111274Q36467838-4C346AF2-6459-4615-ACBD-82272B69D871Q36473265-50DA48F3-DC96-4631-83F3-D0C565690401Q36636341-986E95A0-BA52-4F03-82BB-F763C2336D0CQ37122804-00584653-FFF6-44CF-8D2A-B09B05C5632AQ37180779-1BE7062E-6F3F-4CE2-AFB8-9F91C7A7B4C8Q37328448-E5B049B2-E1C1-4208-99DA-5A1B00BF7A3BQ39613853-F868963E-1052-4C05-8090-BBAC2CEE51D7Q39746652-0BB1FEB4-32E9-441A-B746-6D8E86F05A9AQ39854460-4E70463E-8CFC-44BB-92CB-0A16A374429EQ40281952-3DC84FD7-B128-486B-80CD-FCA684B18F53Q40282242-E0A7ECBF-9F84-498A-86C1-EA1F367B57F5Q40616597-A34F8827-1452-492B-A037-2E09B7BF50D1Q40785841-B3354CCC-B3B7-4DD6-94B3-A71B93F38B58Q41831269-305C0DC3-169C-4B66-A9B8-950784A62D23Q42158152-CB75D44C-FD37-4D54-9F5C-64E7E9454459Q42873758-E84D2938-EC59-4F43-8305-B86B0DE1581CQ50164239-7EF49B6E-9476-4900-8A79-52A23704EF30
P2860
In vitro activity of ampicillin or vancomycin combined with gentamicin or streptomycin against enterococci.
description
1973 nî lūn-bûn
@nan
1973年の論文
@ja
1973年論文
@yue
1973年論文
@zh-hant
1973年論文
@zh-hk
1973年論文
@zh-mo
1973年論文
@zh-tw
1973年论文
@wuu
1973年论文
@zh
1973年论文
@zh-cn
name
In vitro activity of ampicilli ...... eptomycin against enterococci.
@en
type
label
In vitro activity of ampicilli ...... eptomycin against enterococci.
@en
prefLabel
In vitro activity of ampicilli ...... eptomycin against enterococci.
@en
P2093
P2860
P356
P1476
In vitro activity of ampicilli ...... eptomycin against enterococci.
@en
P2093
P2860
P304
P356
10.1128/AAC.4.4.383
P407
P577
1973-10-01T00:00:00Z